Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19

Tomlins and colleagues recently reported in this journal the clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19) in the first UK cohort.1 Interestingly, consistent with evidence supporting the use of CURB-65 as a predictor of mortality secondary to community acquired pneumonia (CAP), non-survivors had a significantly higher median CURB-65 score versus survivors (2.5 versus 1 respectively).

Source: Journal of Infection - May 27, 2020 Category: Infectious Diseases Authors: Yann Nguyen, F élix Corre, Vasco Honsel, Sonja Curac, Virginie Zarrouk, Bruno Fantin, Adrien Galy Source Type: research